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HIGH DOSE INTRAVENOUS ASPIRIN VS LOW DOSE INTRAVENOUS OR 
ORAL ASPiRlN IN EXPERIMENTAL CORONARY VASCULAR INJURY 
Wul T. Hoff, , Jcnsthcn W. Homeister, 
univcfsily of Michigen Medical school, Ann a, MI 
Benedicl R. Lucchesi. 
Inhibition of plalciet aggregation in rcqonse u, vessel wall injury has been used 10 
stabilize acuk coronary syndromes. Delking 100 @ anodal direct cUmnt 10 rhe 
intima of the lefi circumnex caonary IUKQ (LCCA) d canines, ata site 00 moderale 
stenosis, provides a lhrombogenic model of vuular injury. We explored lhe anti- 
lhmmbotic effects of aspirin (ASA) [GpI: 24hnglLg iv, GplIz 4.6 mgkg iv, Gplll: 
4.6 mgkg po 181 pestudy) and placebo (CT’). Time lo lhfomL&s w&s pmlon$ed and 
incidence of tihrombosis was lower in GpI (pcO.05). ‘lluombi wue smaller in Gpl 
(p&OS). Indiufn-labeled platclu dhuawe OD vtsuhu~ (LCC!A/UD ratios) was 
decreased in proximal and distal vessel segmcnu afiu ASA Q~0.05). Ex viva 
amchidonic acid induced ag@ega?ion inalI@oupswilhASA(pcO.OOOl).In 
summary, high dose iv ASA had &aUwy effec& ambiked CBF, prolonged the time 
lo lhrombosis, reduced ~he incidence of lrombosii, reduced lhrombus mass, and 
limiled platelu adherence lo aitca of vessel wall injury. Low dose ASA, given iv or 
p0. was ineff&Xive.Wilh p~~i~ta~linose~ lhrombi,highdosciv ASA maybe 
utefui dcspileti fsft~piuelw~antinue~inpe~~wilhi~~vascularscgrnersu 
vi0 ASA insensitive mtchaniims. 
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DE’lECI’lON OF CORONARY CLOT LYSIS WITI-I AN IMPROVED 
ELISA FOR CROSS-LINKED FIBRIN DEGRADATION 
PRODUmS 
Pa&Rkpnbcrg and Allan S. Jaffe, Washington University, St. 
0 . 
Concentrations of c linked fibrin de 
increase in vivo du pharmacologic 
products (XL-FDP) 
ysis. The extent 10 
c!a lysis has been controversial because of 
overestimation of XL-FDP concentrations with currently available 
ELISAs due lo detection of noncross-linked fibrln(ogen) products 
co~plexccl with XL-FDP by tag antibodies not specific for cross-linked 
fibjln. To overcome this diffkulty, a new ELISA was developed in 
which the monoclonal antibody 386 (AGEN), which is specific for XL- 
FDP, was u@ as both the capture and Q# tinbody. Concentrations 
pf XL-FDP with the new ELISA did not mcrcase in plasma samples 
lncubakd with 2.5 pg/ml t-PA in vitro in the absence of clot. To 
determine whether increases in XL-FDP reflect clot lvsis in vivo, we 
measured concentrations of XL-FDP in 61 pati&ts with acute 
infarction, treated with 100 mg of t-PA . 
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In patients with evidence of 
myoglo 
ncanalization (n=SO) deflncd by rapid rates of increase of 
in or the MM3 isoform of cnatine kinase and coronarv 
LOW BLOOD OXYGEN AFFINITY IMPROVES CARDIAC 
DURING REGIONAL MYOCARDIAL ISCHEklIA IN PIGS 
FUNCTION 
M. Pauliina Ramo, Elizabeth D. Dunlap, Marjorie Cabel, 
Robin Gear, Robert S. France, Ronald W. Millard, Univer- 
sity of Cincinnati, Cincinnati, Ohio, USA 
Definitive experiments characterizing the effects of 
blood oxygen affinity (BOA) on the function of ischemic 
myocardium have not been previously performed. We used 
the osmotic pulse method to incorporate inositol hexa- 
phosphate into red blood cells (RBC) (low affinity, LA, 
P50=35.1 *0.6, n-6). High affinity RBC (HA, P50623.4 
k0.2, n-4) were prepared by incubating with KCNO. These 
methods produce stable changes in BOA (normal affinity, 
NA, P50-31.4i0.5, n-6). Graded myocardial ischemia was 
induced by step reductions in LAD coronary blood flow 
(CBF). At baseline, coronary vascular resistance (CVR) 
was increased by 26.0+4.3% with low BOA and decreased by 
12.0*1.2X with high BOA (p<O.O5). Coronary venous pO2 
(mmHg) was highest in the LA group (42.621 .l 1, lower in 
the NA group (32.5+,1.5), and lowest in the HA group 
(19.7&l .91. CBF could be reduced by 75+3% in the LA 
group, but only by 33k25 in the HA and 58+4% in the NA 
groups, before significant loss of myocardial shortening 
occured. Systemic hemodynamics were stable in both LA 
and NA groups, and at a low 02 delivery (3.6 ml 02/min/ 
100 g) 02 extraction was 66% higher in the LA compared 
to HA and NA groups (p<O.O5). CVA was similar in all 
groups at low CBF. These cardiac and exeracardiac 
responses SUggeSt that low affinity blood may offer 
potential cardiac protection during reduced coronary 
blood flow. 
rim were then perfused with 
shear rates of 150-330 sec.’ 
AGENT 
Heparln 
Control (low shear) 
o.tito.1g 
Bi (bw shear) 81 (high shear) 
6.9&l .O+ 11.7i2.3 
matrobin o&to.29 2.6M.9+ 6.ltl.l 
06, gpcO.01 VB Bl-Heparin 
shear ates there was a 59 ms) (n-55) 
h 
rease in ptl deposition (pcO.05). At 
shear rates there was a 48% decrease in ptl deposition. 
CUBIONS: 1) At shear rates seen in non-stenotic coronary arleries 
robin is signMantly more effective than heparln in reducing plalelet 
deposition at the site of baibon angiopiasty induced Injury. 2) These 
mwils demonstrate the importance of thrombin in platelet thrombus 
formation. 3) Argatrobin may be a 
merxiusion and late restenosis loiio 
I agent in reducing early 
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